Abstract
Listeria monocytogenes (LM) infection induces pyroptosis, a form of regulated necrosis, in host macrophages via inflammasome activation. Here, we examined the role of Mint3 in macrophages, which promotes glycolysis via hypoxia-inducible factor-1 activation, during the initiation of pyroptosis following LM infection. Our results showed that Mint3-deficient mice were more resistant to lethal listeriosis than wild-type (WT) mice. Additionally, the mutant mice showed higher levels of IL-1β/IL-18 in the peritoneal fluid during LM infection than WT mice. Moreover, ablation of Mint3 markedly increased the activation of caspase-1, maturation of gasdermin D, and pyroptosis in macrophages infected with LM in vitro, suggesting that Mint3 depletion promotes pyroptosis. Further analyses revealed that Mint3 depletion upregulates inflammasome assembly preceding pyroptosis via glycolysis reduction and reactive oxygen species production. Pharmacological inhibition of glycolysis conferred resistance to listeriosis in a Mint3-dependent manner. Moreover, Mint3-deficient mice treated with the caspase-1 inhibitor VX-765 were as susceptible to LM infection as WT mice. Taken together, these results suggest that Mint3 depletion promotes pyroptosis in host macrophages, thereby preventing the spread of LM infection. Mint3 may serve as a target for treating severe listeriosis by inducing pyroptosis in LM-infected macrophages.
Similar content being viewed by others
Introduction
Listeria monocytogenes (LM) is a Gram-positive short rod that is highly abundant in the intestinal tracts of ruminants. LM causes listeriosis, which is zoonotically transmitted through contaminated food such as dairy products. In pregnant women, bacteremia arising from the intestinal tract and the liver can infect the fetus and cause meningitis. Listeriosis is frequently observed in modern countries, such as the United States, Australia, and European countries, which consume large quantities of dairy products1,2.
LM serves as an excellent model of an intracellular parasite for immunology-related studies3,4. Upon internalization into host cells, LM escapes from the primary phagosomes and proliferates in the cytoplasm, where it evades host immunity by expressing various pathogenic factors represented by listeriolysin O (LLO). The host mounts an innate immune response to LM by inducing Th1-type cellular immunity. Further, interferon-γ (IFN-γ) produced by Th1 cells activates macrophages, and LM remaining in the cytoplasm is killed by the action of reactive oxygen species (ROS) and nitric oxide (NO)5.
Bacteria-infected macrophages activate a suicidal-death program, called pyroptosis, which clears the field from bacterial growth and contributes to host defense6. LM infection also triggers pyroptosis7,8. Genomic DNA and LLO of LM activate AIM2- or NLRP3 inflammasomes9,10. Subsequently, caspase-1 is activated in an inflammasome-dependent manner11,12, and gasdermin D (GSDMD) is cleaved. The N-terminal fragment of GSDMD forms a polymeric pore on the cell membrane and induces pyroptosis13. Thus, pyroptosis contributes to preventing the expansion of LM infection, although the precise molecular mechanisms underlying the regulation of LM-induced pyroptosis in macrophages remain unknown.
The X11 family member Mint3 (also known as APBA3) activates hypoxia-inducible factor-1 (HIF-1) in the presence of oxygen by suppressing its inhibitor, FIH-1 (refs. 14,15,16,17,18). Mint3 requires the transmembrane protease MT1-MMP to bind and inhibit FIH-1 (refs. 19,20). Thus, Mint3-mediated HIF-1 activation is limited to cells such as macrophages and cancer cells that express MT1-MMP21. Mint3-deficient mice are viable and do not exhibit detectable macroscopic defects22. However, macrophages isolated from these mutant mice are defective in glycolytic ATP synthesis because of decreased HIF-1 activity. Mint3-deficient macrophages are also defective in cytokine production in response to lipopolysaccharide (LPS)22,23.
FIH-1 hydroxylates proteins other than HIF-1α, such as IκBα, which inhibits the nuclear factor-κB (NF-κB) signaling24. Thus, in macrophages, Mint3 inhibition of FIH-1 activity may alter the production of inflammatory cytokines and chemokines through the effect of FIH-1 on HIF-1 and NF-κB signaling. Furthermore, Mint3 contributes to the innate immune response to viral infection25,26 and the survival or growth of cancer cells27,28,29,30,31. Therefore, this study aimed to assess for the involvement of Mint3 in the pathogenesis of listeriosis and protection of the host against LM infection.
Results
Mint3 depletion attenuates severe listeriosis in mice
To determine whether Mint3 contributes to immune responses during LM infection, we first intraperitoneally injected a lethal dose of LM into wild type (WT: C57BL/6) and Mint3–/– mice. LM-infected WT mice appeared visibly ill, as indicated by ruffled fur, slow movements, and >10% reduction of body weight, 4–10 days after infection (Supplementary Fig. 1), whereas Mint3–/– mice appeared more active than WT mice. Consistent with their apparent activity, the final survival rate on day 21 after LM infection was significantly improved in Mint3–/– mice (∼60%) compared with that in WT mice (∼30%; Fig. 1A). One day after LM infection, the bacterial burdens in the spleen (Fig. 1B) and liver (Fig. 1C) were significantly lower in Mint3–/– mice than in WT mice. On the other hand, at later time points (3 and 7 days after LM infection), there was no significant difference in bacterial counts between the strains (Fig. 1B, C).
LM infection activates the AIM2/NLRP3 inflammasome, leading to the release of the cytokines interleukin-1β (IL-1β) and IL-18, which contribute to innate immunity3,9,10,11,12,32. We, therefore, determined the levels of IL-1β and IL-18 in peritoneal lavage fluid harvested from LM-infected mice. IL-1β (Fig. 1D) and IL-18 (Fig. 1E) levels were significantly increased in the peritoneal fluid of Mint3–/– mice 3 days after LM infection. These findings indicate that Mint3 depletion attenuated severe listeriosis and reduced mortality. Furthermore, Mint3 deficiency led to increased production of IL-1β and IL-18, which may have contributed to antibacterial immunity.
Mint3 depletion attenuates LM growth within macrophages
LM can initially survive and grow within macrophages, but later LM infection activates macrophages through the action of IFN-γ derived from Th1 cells, leading to the termination of infection4. Thus, macrophages play an important role in LM infection. Mint3 depletion affects macrophage function owing to reduced HIF-1 activity and ATP production via glycolysis22,23. Thus, we next examined whether Mint3 is required for LM infection and growth within macrophages. Thioglycolate-induced peritoneal macrophages (TG-MFs) and bone marrow-derived macrophages (BMMFs) from WT or Mint3–/– mice were infected with LM in vitro, and then the intracellular bacterial burdens were measured. The intracellular invasion of LM was not affected, but the intracellular growth of LM was significantly suppressed in Mint3–/– TG-MFs (Fig. 2A) and BMMFs (Fig. 2B). Thus, decreased LM growth within macrophages likely contributed to the attenuation of severe listeriosis in Mint3–/– mice.
Mint3 depletion leads to decreased ROS production and increased cell death in LM-infected macrophages
ROS and NO play important roles in the intracellular killing of LM in macrophages5. BMMFs were, therefore, treated with various infectious doses of LM to determine their effects on the production of intracellular ROS and NO. Unexpectedly, Mint3–/– BMMFs produced less ROS (Fig. 3A) and comparable NO (Fig. 3B) relative to WT BMMFs. Thus, the decreased LM growth within Mint3–/– macrophages was not attributed to bacterial killing by increased ROS and NO.
Next, we examined whether Mint3 depletion affects pyroptosis and thereby suppresses LM growth within macrophages. The amount of LDH released from damaged macrophages in the culture supernatant revealed that LM infection was more cytotoxic to Mint3–/– BMMFs (Fig. 3C). Furthermore, imaging analyses showed that LM-infected Mint3–/– BMMFs had a higher death rate than LM-infected WT BMMFs (Fig. 3D, E). Therefore, Mint3 depletion promoted pyroptosis in LM-infected macrophages.
Mint3 deficiency promotes inflammasome activation in macrophages
When LM infects macrophages, genomic DNA and LLO from LM act as stimulators to activate host AIM2 or NLRP3 inflammasomes. Furthermore, activated inflammasomes promote caspase-1-dependent cleavage of GSDMD3,9,10,11,12,32. The N-terminal fragment of GSDMD forms a polymeric pore in the cell membrane, causing pyroptosis of macrophages8,13. Thus, we next investigated whether the inflammasome was activated in Mint3–/– macrophages. Immunoblotting analysis revealed that caspase-1, but not the structurally similar caspase-11, was activated more in LM-infected Mint3–/– BMMFs than in LM-infected WT BMMFs (Fig. 4A, B). In parallel to the activation of caspase-1, the processing of GSDMD was promoted in Mint3–/– BMMFs (Fig. 4C, D).
Upon activation of the inflammasome, one of its components, ASC, clusters to form a speckled structure32. Confocal fluorescence microscopy revealed an increased assembly of ASC in LM-stimulated Mint3–/– BMMFs, as indicated by more numerous ASC-specific speckles than in WT BMMFs (Fig. 4E, F). Despite the similar expression levels of ASC in the total cell lysates (Fig. 4G, H), the immunoblotting analysis results revealed more ASC dimers or oligomers in the Triton X-100-insoluble fraction of the LM-stimulated Mint3–/– BMMFs than that of the LM-stimulated WT BMMFs (Fig. 4I). Furthermore, the levels of IL-1β (Fig. 4J) and IL-18 (Fig. 4K) in the culture supernatants 24 h after LM infection were significantly increased in LM-infected Mint3–/– BMMFs. These findings indicate that Mint3 deficiency activated inflammasomes and efficiently induced pyroptosis in LM-infected macrophages.
Inhibition of glycolysis promotes pyroptosis and confers resistance to LM infection in macrophages
Mint3–/– macrophages exhibit defects in ATP production via glycolysis22,23. We, therefore, investigated whether inhibition of glycolysis altered host resistance to LM infection. For this purpose, we administered the glycolysis inhibitor 2-deoxyglucose (2-DG) intraperitoneally into WT and Mint3–/– mice before LM infection. The survival rate of 2-DG-administrated WT mice recovered to the same level as that in Mint3–/– mice (Fig. 5A). Moreover, 2-DG administration also reduced the LM burdens in the spleen (Fig. 5B) and liver (Fig. 5C) of WT mice 1 day after LM infection to the same levels as in Mint3–/– mice. Furthermore, WT and Mint3–/– BMMFs were infected with LM in the presence of 2-DG, and the intracellular bacterial burdens were analyzed. 2-DG decreased the intracellular proliferation of LM in WT BMMFs to levels comparable to those in Mint3–/– BMMFs (Fig. 5D). However, 2-DG itself did not affect the replication of LM in growth media (Supplementary Fig. 2), consistent with published data33. Next, we examined whether 2-DG promotes pyroptosis in LM-infected macrophages. 2-DG alone did not induce cell death in BMMFs; however, 2-DG increased the death of LM-infected WT BMMFs to the levels of Mint3–/– BMMFs (Fig. 5E). Taken together, Mint3 depletion promotes pyroptosis of LM-infected macrophages via attenuated glycolysis and thereby suppresses intracellular proliferation of LM in macrophages.
Mint3-mediated glycolysis and ROS production control inflammasome activation in LM-infected macrophages
Glycolysis inhibition promoted pyroptosis in LM-infected macrophages. Thus, whether glycolysis controls inflammasome activation was further examined. 2-DG treatment promoted ASC polymerization in LM-infected BMMFs without affecting ASC levels (Fig. 6A–C). In parallel with increased ASC polymerization, 2-DG treatment also promoted caspase-1 activation and GSDMD processing in LM-infected BMMFs (Fig. 6D–G). Thus, glycolysis suppressed inflammasome activation in LM-infected macrophages. Even though 2-DG treatment promoted caspase-1 activation and GSDMD processing, these changes were moderate compared with Mint3 depletion (Fig. 4A, C), suggesting another mechanism by which Mint3 controls inflammasome activation and pyroptosis.
Mint3 depletion decreased ROS production in LM-infected macrophages (Fig. 3A). Therefore, we examined whether glycolysis inhibition also suppressed ROS production in LM-infected WT and Mint3–/– BMMFs. Interestingly, 2-DG treatment increased ROS production in LM-infected BMMFs, and Mint3–/– BMMFs still showed decreased ROS production (Fig. 6H). These results indicate that Mint3 deficiency attenuated ROS production in LM-infected macrophages independent of defects in glycolysis. ROS inactivates caspase-1 via oxidation34. Thus, we examined whether the combined inhibition of glycolysis and ROS induces prominent caspase-1 activation and GSDMD processing, similar to Mint3 deficiency in LM-infected macrophages. 2-DG or the ROS scavenger NAC treatment partially activated caspase-1 and induced GSDMD processing in LM-infected BMMFs; meanwhile, the combination of 2-DG and NAC strikingly induced caspase-1 activation and GSDMD processing (Fig. 6I–K). Thus, Mint3-mediated glycolysis and ROS production coordinately control inflammasome activation and pyroptosis in LM-infected macrophages.
Resistance to LM infection caused by Mint3 deficiency requires activated caspase-1
Since Mint3 depletion rapidly activated the inflammasome and induced pyroptosis of LM-infected macrophages, we investigated whether inhibition of caspase-1 early during LM infection altered resistance to LM infection. For this purpose, WT and Mint3–/– mice were administered with the potent and selective caspase-1 inhibitor (VX-765)35 and then infected with LM. Under these conditions, the survival rate of Mint3–/– mice was almost equivalent to that of WT mice (Fig. 7A). Moreover, 1 day after the infection, the bacterial burdens in the spleen (Fig. 7B) and liver (Fig. 7C) of Mint3–/– mice were increased to the same levels as in WT mice. When WT and Mint3–/– BMMFs were infected in the presence of VX-765, the suppression of intracellular LM growth and enhancement of cell death in Mint3–/– BMMFs were abolished (Fig. 7D, E). Taken together, these results indicate that the resistance of Mint3–/– mice to LM infection requires activated caspase-1.
Discussion
Here, we show that a Mint3-mediated pathway contributes to severe listeriosis in mice. Specifically, caspase-1-dependent processing of GSDMD was enhanced in LM-infected macrophages isolated from Mint3–/– mice, accompanied by strong induction of pyroptosis. In LM-infected macrophages, Mint3 depletion promoted pyroptosis and LM clearance by suppressing glycolysis-dependent inflammasome inactivation and ROS-dependent caspase-1 inactivation. Therefore, bacterial clearance was enhanced after LM infection, and the survival rate of Mint3–/– mice after the infection was increased compared with that in WT mice (Fig. 8). Together, these findings suggest that Mint3 may function as a negative regulator of inflammasome activation and pyroptosis during LM infection by integrating glycolysis and ROS production.
Mint3–/– mice were resistant to LM infection (Fig. 1A). The bacterial burdens in organs after infection with LM in Mint3–/– mice became lower on day 1 of infection, in contrast to WT mice (Fig. 1B). The levels of IL-1β and IL-18 induced by inflammasome activation were significantly higher in Mint3–/– mice on day 3 of infection (Fig. 1C, D). These findings suggest that LM infection activated the inflammasome earlier in Mint3–/– mice, and LM-infected cells, which contributed to the spread of infection, efficiently underwent pyroptosis, leading to improved survival of Mint3–/– mice. This idea is also supported by the finding that a single injection of the caspase-1 inhibitor VX-765 1 h before LM injection increased the LM burden in the liver and spleen and worsened the survival rate in Mint3–/– mice to the levels of WT mice (Fig. 7A–C). In addition to pyroptosis, the defects of motility in Mint3–/– macrophages22,29,30 may partially affect the facile translocation of the LM within macrophages from the abdominal cavity to other organs.
Regulation of inflammasome activation by glycolysis remains ambiguous and controversial36. For example, the glycolytic enzymes hexokinase (HK) 1 and pyruvate kinase isoform 2 (PKM2) promote inflammasome activation, whereas inhibitors of the glycolytic enzymes α-enolase and glyceraldehyde phosphate dehydrogenase promote inflammasome activation37,38,39. In our study, 2-DG, which inhibits hexokinase and phosphoglucoisomerase, promoted the activation of inflammasomes in LM-infected macrophages (Fig. 6). Because the proposed mechanisms of inflammasome activation by HK1 and PKM2 do not necessarily rely on the metabolic flux or the metabolites of glycolysis, these metabolic factors might suppress inflammasome activation, reflecting the data regarding glycolytic inhibitors. Mint3 promotes glycolysis-related genes by activating HIF-1 resulting in enhanced glycolysis in macrophages22,29. Enhanced glycolysis by Mint3 suppressed inflammasome activation and pyroptosis in LM-infected macrophages. Since 2-DG treatment did not further promote pyroptosis in LM-infected Mint3–/– macrophages (Fig. 5E), Mint3-mediated inflammasome suppression might also depend on the metabolic flux and/or metabolites of glycolysis rather than the expression of glycolytic enzymes.
In addition to inflammasome activation, Mint3 promoted ROS levels resulting in oxidative inactivation of caspase-1 and decreased pyroptosis in LM-infected macrophages. ROS-induced oxidation of caspase-1 reduces the activity of this protein in Sod1–/– mice34. In corroboration, NAC treatment increased active caspase-1 in LM-infected WT macrophages (Fig. 6I). Mint3-mediated ROS production in LM-infected macrophages was independent of glycolysis (Fig. 6H). Mint3 can activate the HIF-1 and NF-κB signaling pathways in macrophages26, and both HIF-1 and NF-κB can induce pro-oxidant genes, including NOX2 (refs. 40,41). Thus, Mint3 might promote the expression of pro-oxidant genes and result in ROS production via the HIF-1 and/or NF-κB signaling pathways independent of glycolysis in LM-infected macrophages.
In contrast to the LM infection, LPS and nigericin induced inflammasome activation and IL-1β/IL-18 secretion in Mint3–/– macrophages at the same levels as in WT cells (Fig. 4E–K). Thus, the regulation of inflammasome activation and pyroptosis by Mint3 probably depends on the stimulus. LM mainly activates the AIM2 inflammasome9,10. On the other hand, flagellin of bacteria or the type III secretion system of Gram-positive bacteria activate the NLRC4 inflammasome, and cytosolic LPS of Gram-negative bacteria directly activates caspase-11, which promotes GSDMD cleavage and pyroptosis42. Whether Mint3 also controls other pathways of inflammasome activation and pyroptosis needs to be addressed in future studies. In the context of LM infection, Mint3 exacerbated the disease by suppressing inflammasomes and pyroptosis in macrophages. Interestingly, inflammasome and pyroptosis have been implicated in the progression of degenerative disorders, such as amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease, and inflammatory diseases, such as periodic fever syndrome43. Thus, Mint3-mediated suppression of inflammasomes and pyroptosis in macrophages may play the beneficial roles in these diseases.
In conclusion, Mint3 expressed by macrophages contributes to severe listeriosis. Thus, inhibition of Mint3 may serve as a strategy to prevent the spread of LM infection and severe listeriosis by promoting pyroptosis.
Materials and methods
Mice
Mint3–/– mice have previously been described22 (Riken Center for Developmental Biology Accession No. CDB0589K; http://www2.clst.riken.jp/arg/mutant%20mice%20list.html). These mice were backcrossed ≥10 times with C57BL/6 mice (CLEA Japan, Inc., Tokyo, Japan). The mice were housed under specific pathogen-free conditions. The animal experiments was conducted according to the protocol approved by the president of Kitasato University after the review by the Institutional Animal Care and Use Committee.
Bacteria
Dr. Kikuo Nomoto (Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan) provided an LM EGD strain, which was cultured at 37 °C on tryptic soy agar (TSA) plates containing 0.4% d-glucose.
Reagents
LPS from Escherichia coli 0111:B4, nigericin, and 2-DG [Sigma-Aldrich (St. Louis, MO)]; N-acetyl-L-cysteine (NAC) [Nacalai Tesque (Kyoto, Japan)]; and Belnacasan (VX-765) [Invivogen (San Diego, CA)] were purchased.
LM infection of mice
Sex- and age-matched C57BL/6 and Mint3–/– mice were intraperitoneally injected with 2 × 105 CFUs (unless otherwise indicated) of LM, followed by the assessment of survival rates. Clinical scoring was performed only on surviving mice, based on a previously reported scoring list for a pneumococcal meningitis mouse model44,45. Three items in the list were evaluated: weight loss, activity, and state of fur coat. The range of each scoring parameter was from 0 (no change) to 10 (maximum score), and the changes in each mouse from day 0 to day 7 were plotted in a graph. Organs were lysed and homogenized with sterile water containing 0.2% Triton X-100. Organ lysates were diluted as required and plated onto TSA plates. After incubation at 37 °C overnight, the CFUs per organ were counted. For chemical treatments, C57BL/6 and Mint3–/– mice were intraperitoneally administered 2-DG (500 mg/kg) or VX-765 (50 mg/kg) for 1 h before infection with LM.
Preparation of macrophages and LM stimulation in vitro
TG-MFs were prepared as previously described46. BMMFs were prepared by culturing bone marrow cells for 5–8 days in RPMI1640 medium supplemented with 10% fetal bovine serum and antibiotics (100 IU/mL penicillin and 100 μg/mL streptomycin) containing M-CSF (25 ng/mL, Peprotech, Rocky Hill, NJ). For MF stimulation, MFs (1 × 105) were seeded in 24-well culture plates (Corning, Corning, NY) and incubated overnight. TG-MFs and BMMFs were infected with the indicated doses of LM, and 100 μg/mL gentamicin sulfate (Sigma–Aldrich) was added 1 h after infection to kill the extracellular bacteria. MFs were lysed and homogenized in the lysis buffer, and the lysates were diluted as required and plated onto TSA plates. CFUs were counted after incubation at 37 °C overnight. BMMFs were primed for 6 h with LPS (50 ng/mL) and stimulated with nigericin (5 μM) for 2 h. For chemical reagent treatments, BMMFs were incubated with 2-DG (100 μg/mL), NAC (1 mM), or VX-765 (10 μM) for 1 h before infection with LM.
Cross-linking
ASC components were cross-linked as previously described32 and then collected with centrifugation for 15 min at 6000 × g. The pellets were dissolved in Laemmli sample buffer.
Low-carbon-source medium
LM was cultured in a low-carbon-source medium as previously described33.
Statistical analysis
Statistical analyses were performed using the log-rank test and GraphPad Prism (GraphPad, San Diego, CA, USA). Survival curves were generated using the Kaplan–Meier method. The Mann–Whitney U test and Student’s t-test were used for evaluating the significance of differences between datasets, presented as mean ± SEM or SD; P values <0.05 were considered significant.
References
Farber, J. M. & Peterkin, P. I. Listeria monocytogenes, a food-borne pathogen. Microbiol. Rev. 55, 476–511 (1991).
Vazquez-Boland, J. A. et al. Listeria pathogenesis and molecular virulence determinants. Clin. Microbiol. Rev. 14, 584–640 (2001).
Theisen, E. & Sauer, J. D. Listeria monocytogenes and the inflammasome: from cytosolic bacteriolysis to tumor immunotherapy. Curr. Top. Microbiol. Immunol. 397, 133–160 (2016).
Radoshevich, L. & Cossart, P. Listeria monocytogenes: towards a complete picture of its physiology and pathogenesis. Nat. Rev. Microbiol. 16, 32–46 (2018).
Kimura, A. et al. Aryl hydrocarbon receptor protects against bacterial infection by promoting macrophage survival and reactive oxygen species production. Int. Immunol. 26, 209–220 (2014).
Miao, E. A. et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 11, 1136–1142 (2010).
Doitsh, G. et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505, 509–514 (2014).
Shi, J., Gao, W. & Shao, F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem. Sci. 42, 245–254 (2017).
Sauer, J. D. et al. Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host Microbe 7, 412–419 (2010).
Tsuchiya, K. et al. Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes. J. Immunol. 185, 1186–1195 (2010).
Cervantes, J., Nagata, T., Uchijima, M., Shibata, K. & Koide, Y. Intracytosolic Listeria monocytogenes induces cell death through caspase-1 activation in murine macrophages. Cell. Microbiol. 10, 41–52 (2008).
Hara, H. et al. Dependency of Caspase-1 activation induced in macrophages by Listeria monocytogenes on cytolysin, listeriolysin O, after evasion from phagosome into the cytoplasm. J. Immunol. 180, 7859–7868 (2008).
Liu, X. et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153–158 (2016).
Okamoto, M. & Südhof, T. C. Mint 3: a ubiquitous mint isoform that does not bind to munc18-1 or -2. Eur. J. Cell Biol. 77, 161–165 (1998).
Tanahashi, H. & Tabira, T. X11L2, a new member of the X11 protein family, interacts with Alzheimer’s β-amyloid precursor protein. Biochem. Biophys. Res. Commun. 255, 663–667 (1999).
Okamoto, M., Nakajima, Y., Matsuyama, T. & Sugita, M. Amyloid precursor protein associates independently and collaboratively with PTB and PDZ domains of mint on vesicles and at cell membrane. Neuroscience 104, 653–665 (2001).
Han, J., Wang, Y., Wang, S. & Chi, C. Interaction of Mint3 with Furin regulates the localization of Furin in the trans-Golgi network. J. Cell Sci. 121, 2217–2223 (2008).
Sakamoto, T. & Seiki, M. Mint3 enhances the activity of hypoxia-inducible factor-1 (HIF-1) in macrophages by suppressing the activity of factor inhibiting HIF-1. J. Biol. Chem. 284, 30350–30359 (2009).
Sakamoto, T. & Seiki, M. A membrane protease regulates energy production in macrophages by activating hypoxia-inducible factor-1 via a non-proteolytic mechanism. J. Biol. Chem. 285, 29951–29964 (2010).
Sakamoto, T., Niiya, D. & Seiki, M. Targeting the Warburg effect that arises in tumor cells expressing membrane type-1 matrix metalloproteinase. J. Biol. Chem. 286, 14691–14704 (2011).
Sakamoto, T. & Seiki, M. Integrated functions of membrane-type 1 matrix metalloproteinase in regulating cancer malignancy: beyond a proteinase. Cancer Sci. 108, 1095–1100 (2017).
Hara, T. et al. Deletion of the Mint3/Apba3 gene in mice abrogates macrophage functions and increases resistance to lipopolysaccharide-induced septic shock. J. Biol. Chem. 286, 32542–32551 (2011).
Hara, T., Mimura, K., Seiki, M. & Sakamoto, T. Genetic dissection of proteolytic and non-proteolytic contributions of MT1-MMP to macrophage invasion. Biochem. Biophys. Res. Commun. 413, 277–281 (2011).
Cockman, M. E. et al. Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl Acad. Sci. USA 103, 14767–14772 (2006).
Huai, W. et al. Mint3 potentiates TLR3/4- and RIG-I-induced IFN-β expression and antiviral immune responses. Proc. Natl Acad. Sci. USA 113, 11925–11930 (2016).
Uematsu, T. et al. Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus. Sci. Rep. 6, 37815 (2016).
Nakaoka, H. J. et al. NECAB3 promotes activation of hypoxia-inducible factor-1 during normoxia and enhances tumourigenicity of cancer cells. Sci. Rep. 6, 22784 (2016).
Nakaoka, H. J. et al. Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth. Oncogenesis 6, e334–e334 (2017).
Hara, T. et al. Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes. Proc. Natl Acad. Sci. USA 114, E4416–E4424 (2017).
Hara, T., Murakami, Y., Seiki, M. & Sakamoto, T. Mint3 in bone marrow-derived cells promotes lung metastasis in breast cancer model mice. Biochem. Biophys. Res. Commun. 490, 688–692 (2017).
Kanamori, A. et al. Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1. Oncogene 39, 6218–6230 (2020).
Hara, H. et al. Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat. Immunol. 14, 1247–1255 (2013).
Chico-Calero, I. et al. Hpt, a bacterial homolog of the microsomal glucose-6-phosphate translocase, mediates rapid intracellular proliferation in Listeria. Proc. Natl Acad. Sci. USA 99, 431–436 (2002).
Meissner, F., Molawi, K. & Zychlinsky, A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat. Immunol. 9, 866–872 (2008).
Wannamaker, W. et al. (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18. J. Pharmacol. Exp. Ther. 321, 509–516 (2007).
Próchnicki, T. & Latz, E. Inflammasomes on the crossroads of innate immune recognition and metabolic control. Cell Metab. 26, 71–93 (2017).
Wolf, A. J. et al. Hexokinase is an innate immune receptor for the detection of bacterial peptidoglycan. Cell 166, 624–636 (2016).
Xie, M. et al. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation. Nat. Commun. 7, 1–13 (2016).
Sanman, L. E. et al. Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell death. Elife 5, e13663 (2016).
Yuan, G. et al. Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. J. Cell. Physiol. 226, 2925–2933 (2011).
Morgan, M. J. & Liu, Z. G. Crosstalk of reactive oxygen species and NF-κB signaling NF-κB. Cell Res. 21, 103–115 (2011).
Jorgensen, I., Rayamajhi, M. & Miao, E. A. Programmed cell death as a defence against infection. Nat. Rev. Immunol. 17, 151–164 (2017).
Bedoui, S., Herold, M. J. & Strasser, A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat. Rev. Mol. Cell Biol. 21, 678–695 (2020).
Mook-Kanamori, B., Geldhoff, M., Troost, D., van der Poll, T. & van de Beek, D. Characterization of a pneumococcal meningitis mouse model. BMC Infect. Dis. 12, 71 (2012).
Koopmans, M. M. et al. Characterization of a Listeria monocytogenes meningitis mouse model. J. Neuroinflamm. 15, 1–11 (2018).
Saijo, S. et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8, 39–46 (2007).
Acknowledgements
We thank Taiga Yamazaki, Osamu Takeuchi, and Takashi Fukuyama for their helpful discussions and technical support, and Dr. Kikuo Nomoto (Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan) for providing the LM EGD strain.
Funding
This study was supported by a Grant-in-Aid for research from the Kitasato University Medical Center, JSPS KAKENHI Grant Numbers JP16K09585 and JP19K08935; the Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics to T.U., JSPS KAKENHI Grant Numbers JP15K06829 and JP19K07659; and a P-DIRECT (Project for Development of Innovative Research on Cancer Therapeutics) grant from the Japan Agency for Medical Research and Development to T.S. This study was also supported by JSPS KAKENHI Grant Number JP22220014 to M.S. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
T.U. and T.S. performed the experiments and prepared the Mint3–/– mice. T.U., K.T., N.K., and T.S. analyzed the data. K.T., N.K., M.S., J.-i.I., and S.K. supervised this work. T.U. and T.S. directed the project and wrote the manuscript.
Corresponding authors
Ethics declarations
Ethical approvals
The animal experiments was conducted according to the protocol approved by the president of Kitasato University after the review by the Institutional Animal Care and Use Committee.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by H.-U. Simon
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Uematsu, T., Tsuchiya, K., Kobayashi, N. et al. Mint3 depletion-mediated glycolytic and oxidative alterations promote pyroptosis and prevent the spread of Listeria monocytogenes infection in macrophages. Cell Death Dis 12, 404 (2021). https://doi.org/10.1038/s41419-021-03691-y
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-021-03691-y
This article is cited by
-
Hypoxia-inducible factor-driven glycolytic adaptations in host-microbe interactions
Pflügers Archiv - European Journal of Physiology (2024)
-
Engineered exosomes enriched in netrin-1 modRNA promote axonal growth in spinal cord injury by attenuating inflammation and pyroptosis
Biomaterials Research (2023)
-
hMSCs treatment attenuates murine herpesvirus-68 (MHV-68) pneumonia through altering innate immune response via ROS/NLRP3 signaling pathway
Molecular Biomedicine (2023)